Ibuprofen (Ibuprofen)

REMEDYREPACK INC. · tablet, film coated · NDC 70518-1364

Listed in the FDA National Drug Code directory

Ibuprofen is a prescription medicine made available by REMEDYREPACK INC., on the U.S. market since August 2018. It is marketed under an FDA approval (ANDA ANDA091625), so the FDA has reviewed its safety, effectiveness and manufacturing. A listing proves the product exists; it does not prove that a particular pack is genuine, so compare yours with the official description below.

What the genuine product looks like

From the official FDA label (version of Jul 6, 2026). Compare the colour, shape, imprint and packaging with what you have. Any difference is a reason to ask a pharmacist before taking it.

HOW SUPPLIED Ibuprofen tablets are available in the following strengths, colors and sizes: 600 mg (White to off-white, caplet shape, film coated tablets with "I 7" debossing on one side and plain on the other) NDC: 70518-1364-00 NDC: 70518-1364-01 NDC: 70518-1364-02 NDC: 70518-1364-03 NDC: 70518-1364-04 NDC: 70518-1364-05 NDC: 70518-1364-06 NDC: 70518-1364-07 NDC: 70518-1364-08 NDC: 70518-1364-09 PACKAGING: 30 in 1 BOTTLE PLASTIC PACKAGING: 30 in 1 BLISTER PACK PACKAGING: 20 in 1 BOTTLE PLASTIC PACKAGING: 45 in 1 BOTTLE PLASTIC PACKAGING: 27 in 1 BLISTER PACK PACKAGING: 30 in 1 BOTTLE PLASTIC PACKAGING: 21 in 1 BOTTLE PLASTIC PACKAGING: 30 in 1 BLISTER PACK OUTER PACKAGING: 100 in 1 BOX INNER PACKAGING: 1 in 1 POUCH Store at 20º to 25ºC (68º to 77ºF) [see USP Controlled Room Temperature]. Avoid excessive heat above 40ºC (104ºF). Repackaged and Distributed By: Remedy Repack, Inc. 625 Kol…

Product data on the label: Ibuprofen Ibuprofen SILICON DIOXIDE CROSCARMELLOSE SODIUM HYPROMELLOSE 2910 (5 MPA.S) HYDROXYPROPYL CELLULOSE, UNSPECIFIED MAGNESIUM STEARATE MICROCRYSTALLINE CELLULOSE POLYETHYLENE GLYCOL 400 STARCH, CORN POVIDONE K90 SODIUM LAURYL SULFATE TITANIUM DIOXIDE IBUPROFEN IBUPROFEN white to off-white caplet-shaped tablet I;7

Text on the package panel: DRUG: Ibuprofen GENERIC: Ibuprofen DOSAGE: TABLET, FILM COATED ADMINSTRATION: ORAL NDC: 70518-1364-0 NDC: 70518-1364-1 NDC: 70518-1364-2 NDC: 70518-1364-3 NDC: 70518-1364-4 NDC: 70518-1364-5 NDC: 70518-1364-6 NDC: 70518-1364-7 NDC: 70518-1364-8 NDC: 70518-1364-9 COLOR: white SHAPE: OVAL SCORE: No score SIZE: 17 mm IMPRINT: I;7 PACKAGING: 30 in 1 BOTTLE PLASTIC PACKAGING: 30 in 1 BLISTER PACK PACKAGING: 20 in 1 BOTTLE PLASTIC PACKAGING: 45 in 1 BOTTLE PLASTIC PACKAGING: 27 in 1 BLISTER PACK PACK…

What it is for

INDICATIONS AND USAGE Carefully consider the potential benefits and risks of ibuprofen tablets and other treatment options before deciding to use ibuprofen. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). Ibuprofen tablets are indicated for relief of the signs and symptoms of rheumatoid arthritis and osteoarthritis. Ibuprofen tablets are indicated for relief of mild to moderate pain. Ibuprofen tablets are also indicated for the treatment of primary dysmenorrhea. Controlled clinical trials to establish the safety and effectiveness of ibuprofen tablets in children have not been conducted.

Key warnings

Cardiovascular Thrombotic Events Non-steroidal anti-inflammatory drugs (NSAIDs) cause an increased risk of serious cardiovascular thrombotic events, including myocardial infarction and stroke, which can be fatal. This risk may occur early in treatment and may increase with duration of use (see WARNINGS and PRECAUTIONS) . Ibuprofen tablets are contraindicated in the setting of coronary artery bypass graft (CABG) surgery (see CONTRAINDICATIONS and WARNINGS) . Gastrointestinal Risk NSAIDs cause an increased risk of serious gastrointestinal adverse events including bleeding, ulceration, and perfo…

Excerpts from the FDA label. Always read the leaflet in your pack and ask a pharmacist or doctor about your own situation.

Advertisement

Recalls of this product

No FDA recalls are recorded for NDC 70518-1364. Recalls are listed in FDA enforcement reports from 2004 onward.

Other recent recalls of ibuprofen

Same active ingredient, other companies or packs. Check the company and lot number on your pack.

Class II · Mar 25, 2026 · STRIDES PHARMA INC

Presence of foreign substance: the firm received complaints for a gel-like mass and black particles in the product.

Class II · Apr 16, 2025 · Glenmark Pharmaceuticals Inc., USA

CGMP Deviations

Class III · Nov 27, 2024 · Dr. Reddy's Laboratories, Inc.

Failed Tablet/Capsule Specifications

Class II · Sep 4, 2024 · Dr. Reddy's Laboratories, Inc.

Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.

Class II · Sep 4, 2024 · Dr. Reddy's Laboratories, Inc.

Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.

Class II · Sep 4, 2024 · Dr. Reddy's Laboratories, Inc.

Failed impurities/degradation specifications: results for unknown impurity, were 0.13% and 0.11% respectively, exceeding the 0.10% specification limit.

Class II · Jun 15, 2022 · Mckesson Medical-Surgical Inc. Corporate Office

cGMP deviations: Temperature abuse

Class II · Jun 2, 2021 · Cardinal Health Inc.

CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Most reported side effects for ibuprofenReports to the FDA Adverse Event Reporting System (FAERS), all products with this ingredient
Drug ineffective27,695 reports
Pain19,683 reports
Fatigue19,020 reports
Nausea18,574 reports
Headache16,765 reports
Arthralgia13,653 reports
Dyspnoea13,294 reports
Vomiting13,218 reports
Diarrhoea12,905 reports
Dizziness11,570 reports
Show as table
ItemValue (reports)
Drug ineffective27,695
Pain19,683
Fatigue19,020
Nausea18,574
Headache16,765
Arthralgia13,653
Dyspnoea13,294
Vomiting13,218
Diarrhoea12,905
Dizziness11,570

These counts are reports, not proof that the medicine caused the problem. Popular medicines get more reports simply because more people take them. They are useful for spotting what to watch for, not for comparing medicines.

Official listing

Brand
Ibuprofen
Generic name
Ibuprofen
Company
REMEDYREPACK INC.
Form
tablet, film coated
Route
oral
Type
HUMAN PRESCRIPTION DRUG
Category
ANDA
Listing valid to
Dec 31, 2027
Product NDC
70518-1364

Active ingredients

Ibuprofen
600 mg/1

Packages (4)

The last part of the NDC identifies the pack size. Your box should show one of these.

70518-1364-2 20 tablet, film coated in 1 bottle, plastic (70518-1364-2)
70518-1364-4 27 tablet, film coated in 1 blister pack (70518-1364-4)
70518-1364-5 30 tablet, film coated in 1 bottle, plastic (70518-1364-5)
70518-1364-8 100 pouch in 1 box (70518-1364-8) / 1 tablet, film coated in 1 pouch (70518-1364-9)

Think your pack is fake?

Stop taking it, keep the pack and receipt, and show it to a pharmacist. In the U.S., report it to FDA MedWatch; elsewhere, to your national medicines regulator. How to spot a fake medicine.

Source: openFDA (U.S. Food and Drug Administration) drug directory, labels, enforcement reports and FAERS, retrieved Nov 8, 2026. The FDA notes this data should not be relied on alone for medical decisions. Not medical advice.